Kenneth Munie

Kenneth Munie

Princeton, New Jersey, United States
2K followers 500+ connections

Join to view profile

Activity

Join now to see all activity

Experience

Publications

  • How to Get More from the Cloud: Three Talent Strategies You’re Probably Neglecting

    California Management Review

    Why are most companies not getting their money’s worth from cloud investments? There’s a frustratingly simple answer: They are not putting their people first. For access, training, or collaboration. Companies need to up their game on all three fronts.

    See publication

  • All to win? Or all to lose? Driving digitization in Life Sciences

    Accenture

    Digitization ought to be a no-brainer for life sciences. Accenture research shows that digitization will be fueling almost one-third of the growth and an estimated 40% of the profitability in the pharmaceutical market by 2020.

    Other authors
    See publication

  • Capturing the $100 Billion Opportunity for Life Sciences: Are You a Digital Transformer or Follower?

    Accenture

    With the healthcare industry poised for radical changes, traditional life sciences companies must decide whether they will lead the charge by becoming a digital transformer or let this shift of value happen around them, and accept being a digital follower. Companies that aspire to become digital transformers must take a fresh look at their capabilities and business models and address a key question: How can digital unlock significant value for our business and patients?

    The paper…

    With the healthcare industry poised for radical changes, traditional life sciences companies must decide whether they will lead the charge by becoming a digital transformer or let this shift of value happen around them, and accept being a digital follower. Companies that aspire to become digital transformers must take a fresh look at their capabilities and business models and address a key question: How can digital unlock significant value for our business and patients?

    The paper defines and sizes the market where we see the biggest value in the US branded pharmaceutical market. It also details an example in diabetes and outlines five critical actions for life sciences companies to take to become a digital transformer.

    Other authors
    See publication

  • The Pulse

    Wharton - University of Pennsylvania

    Life sciences businesses are facing a number of challenges associated with meeting new
    consumer expectations and behavior patterns, including more rigorous support for the
    efficacy and cost-effectiveness of individual treatments. Life sciences companies must also
    adapt to changing healthcare industry fundamentals, including alignment between providers
    and payors, in addition to a wave of government legislation. The Pulse sat down with Tony
    Romito and Ken Munie, both Managing…

    Life sciences businesses are facing a number of challenges associated with meeting new
    consumer expectations and behavior patterns, including more rigorous support for the
    efficacy and cost-effectiveness of individual treatments. Life sciences companies must also
    adapt to changing healthcare industry fundamentals, including alignment between providers
    and payors, in addition to a wave of government legislation. The Pulse sat down with Tony
    Romito and Ken Munie, both Managing Directors in Accenture’s Life Sciences Practice, to learn
    more.

    See publication

  • Going for Growth Balancing Price and Cost to Drive High Performance in a Recovering Global Economy

    Accenture

    As the effects of the recent economic downturn recede, companies once again are turning their attention toward growth. At the same time, many organizations remain concerned about their cost structures. Indeed, recent Accenture experience and research confirms that companies must consider both price and cost levers when seeking profitable growth.

    See publication

  • Time to Get Together: Delivering Improved Health Outcomes through Pharmaceutical and Payer Collaboration

    Accenture

    With integration increasingly becoming the watchword in the North American life sciences industry, pharmaceutical companies must collaborate with payers and align interests to remain ahead of their competitors in the ever-evolving health care marketplace. These health care stakeholders will need to partner in the near and long term to reduce cost while increasing or maintaining quality—as demanded by patients and providers—across the entire care continuum.

    See publication

More activity by Kenneth

View Kenneth’s full profile

  • See who you know in common
  • Get introduced
  • Contact Kenneth directly
Join to view full profile

Other similar profiles

Explore more posts

Explore collaborative articles

We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.

Explore More

Add new skills with these courses

See all courses